Stiff-Person Case Shows Why Poor Lorazepam Response Does Not Exclude Neurological Disease

An atypical neurological presentation remained diagnostically important despite limited initial response to symptomatic medicines.

What the supplied paper reports

The report followed a woman with diplopia and abnormal muscle tension over four years. Baclofen and lorazepam initially provided poor relief, and psychiatric and oculomotor explanations were considered. More typical stiff-person features and positive GAD antibodies later emerged. Symptoms worsened after tandospirone initiation and improved following broader treatment changes including immunotherapy.

What the findings cannot establish

This single case does not establish that tandospirone caused deterioration or that a benzodiazepine response is a reliable diagnostic test. Natural disease evolution, immune activity and multiple treatment changes complicate attribution. Antibody findings must be interpreted with the clinical syndrome.

Implications for forensic review

An expert should distinguish failure of symptomatic relief from evidence against an underlying organic disorder. Reconstruct the evolving examination, testing and medication sequence rather than judging the whole course from an early treatment response. The report supports diagnostic reassessment when neurological findings persist or change.

Source and related reading

Source reviewed: Aggravation of stiff person syndrome with ophthalmoplegia after tandospirone initiation a case repor (PMC13083095). The forensic applications above are interpretive analysis of the supplied paper.